Literature DB >> 6549166

Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction.

S Drajer, H Cercós, H Torres, A Vazquez, J L Cohn, N Romero, G Faerman, S Soifer, C M Nijensohn.   

Abstract

Haemodynamic monitoring, using a Swan-Ganz balloon catheter, was done in 14 patients with pump failure associated with acute myocardial infarction, before and for 8 h after single 6 mg oral dose of molsidomine. The following changes effects were found: HR fell by 1.6 to 4.7% (significant at 4th hour; p less than 0.05); SBP was 8.4% lower after 1 h (p less than 0.05); PCP was decreased by approximately 30%, a significant effect that lasted for 8 hours (p less than 0.002). CI did not change significantly, although individual analysis showed it to have increased in 6 out of 12 cases. Stroke volume index was increased by about 6% (significant after 1 h, p less than 0.025). The left ventricular stroke work index also increased from 9.8 to 24.5% (significant after 1 and 4 h, p less than 0.01 and 0.025). These findings show the beneficial haemodynamic effects of molsidomine in pump failure complicating acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6549166     DOI: 10.1007/bf00549588

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  16 in total

1.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

2.  [Effect of Molsidomin on the hemodynamics and working tolerance of patients with angina pectoris].

Authors:  J Slany; H Mösslacher; R Schmoliner; G Krinik
Journal:  Med Welt       Date:  1976-12-03

3.  Haemodynamic effects of molsidomin.

Authors:  K R Karsch; K P Rentrop; H Blanke; H Kreuzer
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

4.  [Studies on the influence of Molsidomin on coronary heart disease (author's transl)].

Authors:  E Jansen; H Klepzig
Journal:  Med Klin       Date:  1976-11-19

5.  Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure: results of a Veterans Administration cooperative study.

Authors:  J N Cohn; J A Franciosa; G S Francis; D Archibald; F Tristani; R Fletcher; A Montero; G Cintron; J Clarke; D Hager; R Saunders; F Cobb; R Smith; H Loeb; H Settle
Journal:  N Engl J Med       Date:  1982-05-13       Impact factor: 91.245

6.  Acute double blind trial of a new anti-anginal drug: molsidomine.

Authors:  S Guerchicoff; A Vazquez; H Kunik; S Drajer; F Díaz
Journal:  Eur J Clin Pharmacol       Date:  1978-06-19       Impact factor: 2.953

7.  [An improved exercise test in coronary-heart disease: effect of molsidomin on erogometrically controlled exercise (author's transl)].

Authors:  G Blazek; H Heeger; F Kubicek
Journal:  Dtsch Med Wochenschr       Date:  1977-01-21       Impact factor: 0.628

8.  Correlative classification of clinical and hemodynamic function after acute myocardial infarction.

Authors:  J S Forrester; G A Diamond; H J Swan
Journal:  Am J Cardiol       Date:  1977-02       Impact factor: 2.778

9.  Hemodynamic effects of molsidomine vasodilatory therapy in acute myocardial infarction.

Authors:  M Aptecar; C A Otero y Garzon; A Vasquez; S Varini; L Collia; A Esteguy; S Caruso
Journal:  Am Heart J       Date:  1981-04       Impact factor: 4.749

10.  [Effect of molsidomine on hemodynamics and myocardial ischemia in patients with acute myocardial infarction (author's transl)].

Authors:  W D Bussmann; K Neidl; M Kaltenbach
Journal:  Klin Wochenschr       Date:  1982-01-15
View more
  1 in total

1.  Comparison of haemodynamic effects of nifedipine and molsidomine in patients with coronary artery disease.

Authors:  M Kyriakidis; G Vyssoulis; P Sfikakis; C Kyriakidis; C Pitsavos; K Valsamis; V Nomikos; P Toutouzas
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.